Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment

Kidney International

Volumn 50, Issue 2, 1996, Pages 627-634

  Soulis, Tina ^a   Cooper, Mark E ^b   Vranes, Dimitria ^b   Bucala, Richard ^b   Jerums, George ^b  

^a AUSTIN HEALTH   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; DRINKING WATER; INSULIN ZINC SUSPENSION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FLUORESCENCE; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; INSULIN TREATMENT; KIDNEY TUBULE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEINURIA; RADIOIMMUNOASSAY; RAT; STREPTOZOCIN DIABETES; URINARY EXCRETION;

EID: 0029787750     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.358     Document Type: Article

References (50)

1. VAN BOEKEL MA, HOENDERS HJ: Glycation of crystallins in lenses from aging and diabetic individuals. FEBS Lett 314:1-4, 1992
2. DYER DG, DUNN JA, THORPE SR, BAILIE KE, LYONS TJ, MCCANCE DR, BAYNES JW: Accumulation of maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463-2469, 1993
3. MONNIER VM, SELL DR, NAGARAJ RH, MIYATA S, GRANDHEE S, ODETTI P, IBRAHIM SA: Maillard reaction-mediated molecular damage to extracelluar matrix and other tissue proteins in diabetes, aging and uremia. Diabetes 41(Suppl 2):36-41, 1992
4. MAKITA Z, BUCALA R, RAYFIELD EJ, FRIEDMAN EA, KAUFMAN AM, KORBET SM, BARTH RH, WINSTON JA, FUH H, MANOGUE KR, CERAMI A, VLASSARA H: Reactive glycosylation end products in diabetic uraemia and treatment of renal failure. Lancet 343:1519-1522, 1994
5. BROWNLEE M: Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 43:836-41, 1994
6. MAKITA Z, VLASSARA H, RAYEIELD E, CARTWRIGHT K, FRIEDMAN E, RODBY R, CERAMI A, BUCALA R: Hemoglobin-AGE: A circulating marker of advanced glycosylation. Science 258:651-653, 1992
7. SOULIS-LIPAROTA T, COOPER ME, PAPAZOGLOU D, CLARKE B, JERUMS G: Retardation by aminoguanidine of development of albuminuria, mesangial expansion and tissue fluorescence in the streptozocin-induced diabetic rat. Diabetes 40:1328-1334, 1991
8. NICHOLLS K, MANDEL TE: Advanced glycosylation end-products in experimental murine diabetic nephropathy: Effect of islet isografting and of aminoguanidine. Lab Invest 60:486-491, 1989
9. ELLIS EN, GOOD BH: Prevention of glomerular basement thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 40:1016-1019, 1991
10. SCHMIDT FH: Enzymatic determination of glucose and fructose simultaneously. Klin Wochenschr 39:1244-1247, 1961
11. COOPER ME, ALLEN TJ, MACMILLAN P, CLARKE B, O'BRIEN RC, JERUMS G, DOYLE AE: Effects of genetic hypertension on diabetic nephropathy in the rat: Functional and structural characteristics. J Hypertens 6:1009-1016, 1991
12. BUNAG RD: Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34:279-282, 1973
13. COOPER ME, O'BRIEN RC, ALLEN TJ, JERUMS G, DOYLE AE: Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Kidney Int 41:898-903, 1992
14. BRADFORD MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
15. SOULIS T, COOPER ME, LAYTON G, ALLEN T, JERUMS G: aminoguanidine reduces tissue fluorescence but not albuminuria in diabetic rats, in Proceedings of Glycated Proteins in Diabetes Mellitus, edited by RYALL RG, Adelaide, University of Adelaide, 1988, pp 310-320
16. MAKITA Z, VLASSARA H, CERAMI A, BUCALA R: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138, 1992
17. SALACINSKI PRP, MCLEAN C, SYKES JEC, CLEMENT-JONES W, LOWRY PJ: Iodination of proteins, glucoproteins and peptides using a solid phase oxidising agent, 1,3,4,6-1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Anal Biochem 117:136-146, 1981
18. STEGEMANN H, STALDER K: Determination of hydroxyprotine. Clin Chim Acta 18:267-273, 1967
19. ANDREWS PM, COFFEY AK: A technique to reduce fixation artifacts to kidney proximal tubules. Kidney Int 25:964-968, 1984
20. JENSEN EB, GUNDERSEN HJG, OSTERBY R: Determination of membrane thickness distribution from orthogonal intercepts. J Microsc (Oxford) 115:19-33, 1979
21. MAUER SM, STEFFES MW, ELLIS EN, SUTHERLAND DER, BROWN DM, GOETZ FC: Structure-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
22. RASCH R: Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. (abstract) Diabetologia 17:243, 1979
23. ODETTI PR, BORGOGLIO A, DE PASCALE A, ROLANDI R, ADEZATI L: Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin. Diabetes 39:796-780, 1990
24. BROWNLEE M, VLASSARA H, KOONEY A, ULRICH P, CERAMI A: Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632, 1986
25. MAKITA Z, RADOFF S, RAYFIELD EJ, YANG Z, SKOLNIK E, DELANEY V, FRIEDMAN EA, CERAMI A, VLASSARA H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
26. ITAKURA M, YOSHIKAWA H, BANNAI C, KATO M, KUNIKA K, KAWAKAMI Y, YAMAOKA T, YAMASHITA K: Aminoguanidine decreases urinary albumin and high-molecular-weight proteins in diabetic rats. Life Sci 49:889-897, 1991
27. EDELSTEIN D, BROWNLEE M: Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats. Diabetologia 35:96-97, 1992
28. O'BRIEN RC, COOPER ME, JERUMS G, DOYLE AE: The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy. Diabetes 42:604-609, 1993
29. HAMMES HP, BROWNLEE M, EDELSTEIN D, SALECK M, MARTIN S, FEDERLIN K: Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia 37:32-35, 1994
30. CAMERON NE, COTTER MA, DINES K, LOVE A: Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozocin-diabetic rats. Diabetologia 35:946-950, 1992
31. HUIJBERTS MSP, WOLFFENBUTTEL BHR, CRIJNS FRL, NIEUWENHUIJZEN KRUSEMAN AC, BEMELMANS MHA, STRUIJKER BOUDIER HAJ: Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozocin-diabetic rats. Diabetologia 37:10-14, 1994
32. SOULIS T, BERKA J, THALLAS V, MCWILLIAM B, MURRAY-MCINTOSH RP, GILBERT R, NEALE TJ, COOPER ME: Advanced glycation end products and the receptor for advanced glycation end products co-localise in organs undergoing diabetic microvascular injury. Diabetes (IDF) Proc 10F, KOBE, p 116, 1994
33. BRETT J, SCHMIDT AM, YAN SD, ZOU YS, WEIDMAN E, PINSKY D, NOWYGROD R, NEEPER M, PRZYSIECKI C, SHAW A, MISHELI A, STERN O: Survey of the distribution of a newly characterised receptor for advanced glycation end products in tissues. Am J Pathol 143:1699-1712, 1993
34. BAYNES JW: Role of oxidative stress in the development of complications in diabetes. Diabetes 40:405-412, 1991
35. FU MX, WELLS-KNECHT KJ, BLACKLEDGE JA, LYONS TJ, THORPE SR, BAYNES JW: Glycation, glycooxidation and cross-linking of collagen by glucose. Diabetes 43:676-683, 1994
36. SOULIS-LIPAROTA T, COOPER ME, DUNLOP M, JERUMS G: The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the sprague dawley rat. Diabetologia 38:387-394, 1995
37. STEFFES MW, OSTERBY R, CHAVERS B, MAUER SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077-1081, 1989
38. ANDERSON SS, KIM Y, TSILIBARY EC: Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation. Kidney Int 46:1359-1367, 1994
39. COHEN MP, ZIYADEH FN: Amadori glucose adducts modulate measangial cell growth and collagen gene expression. Kidney Int 45:475-487, 1994
40. SABATINI M, SANSONE G, UCCELLO F, GILIBERTI A, CONTE G, ANDREUCCI VE: Early glycosylation products induce glomerular hyperfiltration in normal rats. Kidney Int 42:875-881, 1992
41. HIROSE, K, OSTERBY R, NOZAWA M, GUNDERSEN HGJ: Development of glomcrular lesions in experimental long-term diabetes in the rat. (abstract) Kidney Int 21:689, 1982
42. MAUER SM, STEFFES MW, AZAR S, BROWN DM: Effects of dietary protein content in streptozotocin-diabetic rat. (abstract) Kidney Int 35:48, 1989
43. STEFFES MW, BROWN DM, BASGUN JM, MAUER SM: Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats. (abstract) Diabetes 29:509, 1980
44. SKOLNIK E, YANG Z, MAKITA Z, RADOFF S, KIRSTEIN M, VLASSARA H: Human mesangial cell receptors for glucose-modified proteins. Potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939, 1991
45. MCLENNAN SV, FISHER EJ, YUE DK, TURTLE JR: High glucose concentration causes a decrease in mesangium degradation. Diabetes 43:1041-1045, 1994
46. YANG CW, VLASSARA H, PETEN EP, HE CJ, STRIKER GE, STRIKER LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91:9436-9440, 1994
47. VLASSARA H, STRIKER EJ, TEICHBERG S, FUH H, LI YM, STEFFES M: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci USA 91:11704-11708, 1994
48. HAMMES H-P, SYED ALI S, UHLMANN M, WEISS A, FEDERLIN K, GEISEN K, BROWNLEE M: Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats. Diabetologia 38: 269-273, 1995
49. MITSUHASHI T, NAKAYAMA H, ITOH T, KUWAJIMA S, AOKI S, ATSUMI T, KOIKE T: Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat. Diabetes 42:826-832, 1993
50. BEISSWENGER PJ, MOOER LL, BRINCK-JOHNSEN T, CURPHEY TJ: Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212-217, 1993